OLMA - Olema Pharmaceuticals, Inc.

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 10.74

Open

$ 10.60

Bid

$ 10.15 x 15

Ask

$ 12.09 x 10

Day's Range

$ 10.41 - $ 11.06

52 Week Range

$ 2.86 - $ 13.51

Volume

1,218,126

Average Volume

Market Cap

920.72M

Beta (5Y Monthly)

$ 2.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-18-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-11-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-09-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-17-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Initiates Coverage On Olema Pha...
10/08/2025 12:44:45

Guggenheim analyst Brad Canino initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Pri...

12 Health Care Stocks Moving In Friday's I...
09/05/2025 17:06:13

Oppenheimer Maintains Outperform on Olema ...
09/03/2025 18:55:24

Oppenheimer analyst Matthew Biegler maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and maintains $22 price ...

Olema Oncology Announces Trial Agreement W...
09/02/2025 11:06:11

JP Morgan Maintains Overweight on Olema Ph...
08/14/2025 15:36:14

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and raises the price target fr...

Citigroup Maintains Buy on Olema Pharmaceu...
08/12/2025 11:28:08

Citigroup analyst Yigal Nochomovitz maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target fro...

Olema Pharmaceuticals Q2 EPS $(0.51) Misse...
08/11/2025 20:14:35

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate ...

12 Health Care Stocks Moving In Monday's I...
06/02/2025 17:06:00

Goldman Sachs Maintains Buy on Olema Pharm...
05/14/2025 15:06:37

Goldman Sachs analyst Richard Law maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from ...

Oppenheimer Maintains Outperform on Olema ...
05/14/2025 14:28:03

Oppenheimer analyst Matthew Biegler maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and lowers the price tar...

Olema Pharmaceuticals Q1 EPS $(0.36) Beats...
05/13/2025 20:04:58

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of...

why-sable-offshore-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket

Why Sable Offshore Shares Are Trading High...
05/12/2025 09:13:23

HC Wainwright & Co. Reiterates Buy on Olem...
04/28/2025 12:10:55

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

why-sangamo-therapeutics-shares-are-trading-higher-by-around-40-here-are-20-stocks-moving-premarket

Why Sangamo Therapeutics Shares Are Tradin...
04/04/2025 09:20:41

JP Morgan Maintains Overweight on Olema Ph...
03/28/2025 12:49:07

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and lowers the price target fr...

Olema Oncology To Present Preclinical Data...
03/25/2025 20:35:06

Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical com...

Oppenheimer Reiterates Outperform on Olema...
03/19/2025 16:04:48

Oppenheimer analyst Matthew Biegler reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and lowers the price ta...

HC Wainwright & Co. Reiterates Buy on Olem...
03/19/2025 10:17:18

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

Olema Pharmaceuticals Q4 2024 GAAP EPS $(0...
03/18/2025 20:02:21

li-auto-xponential-fitness-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Li Auto, Xponential Fitness And Other Big ...
03/14/2025 12:12:55